Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Sangeeta N. Bhatia

At a glance: Sangeeta N. Bhatia is Director at Vertex Pharmaceuticals (VRTX). Their latest SEC Form 4, filed Nov 18, 2026, reported a sale of $148K. On file: 0 purchase lines ($0) and 3 sale lines ($416K).

Disclosed holdings: about $2.4M of VRTX stock: 4,653 shares reported on their latest Form 4 (filed Nov 18, 2026), valued at the Nov 19, 2026 close of $521.30. This counts only VRTX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Director at Vertex Pharmaceuticals Inc / Ma (VRTX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $416K

Sangeeta N. Bhatia's InsiderPrint

3 trades from SEC Form 4 filings, 2026 to 2026, drawn as one fingerprint.

InsiderPrint of Sangeeta N. Bhatia: 3 trades, 2026 to 20262026: 0 buys, 3 sales

Reading this print: Almost only sells, trading about 3 times a year, typically $135K a trade; most sales are on a pre-planned 10b5-1 schedule.

  • Bump outward: a purchase (0)
  • Dent inward: a sale (3)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. Kyle WismansCFO · XPO · 100% match
  2. John DabiriDirector · NVDA · 100% match
  3. Kaigham GabrielDirector · TRMB · 100% match
  4. Michael KiernanChief Revenue Officer · NXDR · 100% match
  5. Sean F. MoranCFO · CRBP · 100% match

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Nov 18SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 2714,653 held (−6%) $547.86 $148K -4.8%
May 5SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 3184,924 held (−6%) $423.73 $135K +23.0%
Feb 18SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 2664,299 held (−6%) $500.00 $133K +4.3%
  • Sell

    Director Sangeeta N. Bhatia sold $148K of VRTX at $547.86 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Sangeeta N. Bhatia sold $135K of VRTX at $423.73 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Sangeeta N. Bhatia sold $133K of VRTX at $500.00 — pre-scheduled 10b5-1 plan sale.

Follow Sangeeta N. Bhatia

Get one email when Sangeeta N. Bhatia files a new purchase or sale. Free.

At most one email a day about Sangeeta N. Bhatia, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.